Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs

JACC: Cardiovascular Interventions

Volumn 3, Issue 7, 2010, Pages 723-730

  Van Den Heuvel, Mieke ^a,b   Sorop, Oana ^a   Batenburg, Wendy W ^b   Bakker, Charlotte L ^a   De Vries, René ^b   Jan Koopmans, Sietse ^c   Van Beusekom, Heleen M M ^a   Duncker, Dirk J ^a   Jan Danser, A H ^b   Van Der Giessen, Willem J ^a,d  

^a Thoraxcenter ^*  (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

coronary; drug eluting stent; endothelial function; endothelium derived hyperpolarizing factors; microcirculation

Indexed keywords

BRADYKININ; CYCLIC GMP; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRATE; NITRIC OXIDE; PACLITAXEL; RAPAMYCIN; BIOLOGICAL FACTOR; CARDIOVASCULAR AGENT; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; METAL; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STENT; SWINE; ANGIOCARDIOGRAPHY; ANIMAL; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG EFFECT; FEMALE; INSTRUMENTATION; MALE; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PROSTHESIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; BIOLOGICAL FACTORS; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; MALE; METALS; MICROCIRCULATION; NITRIC OXIDE; PACLITAXEL; PROSTHESIS DESIGN; SIROLIMUS; STENTS; SWINE; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 78049524509     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.05.003     Document Type: Article

References (25)

1. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006;354:483-95.
2. Fuke S, Maekawa K, Kawamoto K, et al. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007;71:220-5.
3. Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006;27:166-70.
4. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231-6.
5. Togni M, Raber L, Cocchia R, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007;120: 212-20.
6. Shin DI, Kim PJ, Seung KB, et al. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction. Int Heart J 2007;48:553-67.
7. van den Heuvel M, Sorop O, van Beusekom HM, van der Giessen WJ. Endothelial dysfunction after drug eluting stent implantation. Minerva Cardioangiol 2009;57:629-44.
8. Pendyala LK, Li J, Shinke T, et al. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. J Am Coll Cardiol Intv 2009;2:253-62.
9. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.
10. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 2000;279:H459-65.
11. Thollon C, Fournet-Bourguignon MP, Saboureau D, et al. Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br J Pharmacol 2002;136:1153-61.
12. van der Giessen WJ, Sorop O, Serruys PW, Peters-Krabbendam I, van Beusekom HM. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing. J Am Coll Cardiol Intv 2009;2:284-90.
13. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: are human and animal studies comparable? Heart 2003;89:133-8.
14. Dick GM, Katz PS, Farias M III, et al. Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. Am J Physiol Heart Circ Physiol 2006;291:H2997-3002.
15. Fallavollita JA, Malm BJ, Canty JM Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003;92: 48-55.
16. Batenburg WW, de Vries R, Saxena PR, Danser AH. L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J Hypertens 2004;22:1927-36.
17. Batenburg WW, Popp R, Fleming I, et al. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br J Pharmacol 2004;142:125-35.
18. van Beusekom HM, Saia F, Zindler JD, et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 2007;28:974-9.
19. Batenburg WW, Garrelds IM, van Kats JP, Saxena PR, Danser AH. Mediators of bradykinin-induced vasorelaxation in human coronary microarteries. Hypertension 2004;43:488-92.
20. Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis. Heart 1997;78: 493-8.
21. Lerman A, Sandok EK, Hildebrand FL Jr., Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992;85:1894-8.
22. Alexandre J, Batteux F, Nicco C, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006;119:41-8.
23. Larsen BT, Gutterman DD, Sato A, et al. Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors. Circ Res 2008;102:59-67.
24. Gutterman DD, Miura H, Liu Y. Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 2005;25:671-8.
25. Kuga T, Egashira K, Mohri M, et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation 1995;92:183-9.